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WE investigated whether Clostridium difficile
toxin alters colonic tissue levels of vasoactive
intestinal peptide (VIP) at the expense of changes
in colonic motility in the isolated perfused rabbit
left colon. Colonic inflammation was induced by
the intracolonic administration of 10-8M C. diffl-
cile toxin. Strain gauge transducers were sewn
onto the serosal surface of the colon to evaluate
colonic motility. C. difflcile administration
produced histologic changes consistent with epi-
thelial damage. This was associated with an
increased production of prostaglandin E2 and
thromboxane B2. Tissue levels of VIP but not sub-
stance P were significantly reduced. This was
associated with an increased number of contrac-
tions per minute and an average force of each
colonic contraction. These results suggest that
tissue levels of VIP are suppressed by C. difflcile
and may participate in colonic dysmotility during
active inflammation.
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Introduction
Clostridium difficile toxin is the causative agent
of pseudomembranous colitis. This disease entity
is associated with watery diarrhoea and altered
motility, and is often effectively treated with
enteral antibiotics. Colonic neuropeptides such
as VIP and substance P are abundant in the gut
and maintain various physiological functions,
such as regulation of colonic motility. We have
previously demonstrated that platelet-activating
factor (PAF) increases colonic tissue levels of VIP
and substance P which were inhibited by a spe-
cific PAF antagonist.
2 In contrast, in further
studies we found that trinitrobenzene (TNB)
suppresses levels of these neuropeptides, which
were ameliorated by neural blockade.3 The aim
of the present study was to evaluate the possible
role of endogenous VIP and substance P in the
dysmotility changes of the left colon of the rabbit
to Clostridium difficile toxin.
Materials and Methods
The experimental procedure for producing
colonic inflammation by other agents known to
induce colitis in the isolated rabbit colon has
been reported previously.
4 After isolating the
colon, it was placed on a temperature controlled
base, humidified whole organ perfusion appara-
tus (Mx International, Aurora, CO) and allowed
to equilibrate with an intra-arterial Kreb’s Ringers
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bicarbonate (KRB) infusion for the first 30 min
period. This was followed by the intraluminal
infusion of 10-8M C. difficile toxin while con-
tinuing intra-arterial infusion of KRB for 30 min.
At the end of this period, C. difficile was dis-
continued and the colon was allowed to recover
for 30 min, infusing only KRB intra-arterially. In a
separate set of experiments, KRB was infused
intraluminally during the entire 90 min period.
Strain gauge transducers were sewn onto the
serosal surface of the colon to measure colonic
motility. Motility was calculated as four indices:
(1) contractions/min; (2) peak force per contrac-
tion measured in grams; (3) average force per
contraction; and (4) the minute motility index
(MMI) calculated as the sum of the contractions,
weighed by the peak force, and expressed as a
per minute average. At the end of the experi-
ment, tissue samples of colon were taken and
immersed in liquid nitrogen and then stored at
-70C. A second section of colon was taken and
evaluated histologically to determine the extent
of inflammation. Tissue levels of prostaglandin E2
(PGE2), thromboxane B2 (TxB2), VIP and sub-
stance P were determined by well described
radioimmunoassays.’5
Results
No colitis was observed in KRB treated colons.
C. difficile treated colons demonstrated evidence
of inflammation that was confined to the mucosa
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Table 1. The effect of C. difficile on tissue PGE2, TxB2, VIP,
substance P and colonic motility
KRB C. difficile
(n=4) (n=4)
Tissue VIP levels 221.2 ___
31.6 107.6 ___
16.4"
Tissue SP levels 164.6 ___
27.7 179.1 ___
13.5
Tissue PGE2 levels 25.2 -I- 6.4 174.8 ___
31.9"
Tissue TxB2 levels 18.7 ___
5.4 32.4 ___
8.8*
Contractions/min 10.9 ___
3.5 14.7 -I- 3.3*
Peak force 2.5 ___
O. 11 1.9 ___
0.09
Average force 0.44 ___
0.3 0.72 ___
0.08*
MMI 15.1 -t- 3.5 16.2 ___
4.1
*p < 0.05, C. difficile and KRB.
apg/mg wet tissue.
bpeak force per contraction.
CAverage force per contraction.
dMinute Motihty Index.
and submucosa and did not involve the muscu-
lads propria. Tissue concentrations of PGE2 and
TxB2 in C. difficile treated colons were sig-
nificantly increased compared to KRB treated
colons. Tissue levels of rIP were significantly
suppressed while levels of substance P remained
unchanged in C. difficile treated colons. Motility
results demonstrated that C. difficile increased
both the number of contractions per min and
the average force per contraction (Table 1).
Discussion
Our results demonstrate that C difficile toxin
produces a significant inflammatory response and
altered colonic motility that correlates with altera-
tions in tissue levels of VIP. A recent study
6 uti-
lizing C difleicile toxin A on rabbit distal colonic
loops demonstrated an increased number of
spike bursts without altering slow-wave fre-
quency that was associated with increased pro-
duction of prostanoids and leukotrienes. The
authors concluded that this result may be indir-
ect resulting from the production of motility
altering arachidonic acid metabolites. The results
were similar to that seen by Gilbert7 who
demonstrated that similar alterations in ileal cir-
cular smooth muscle myoelectric and contractile
activity were seen with toxin A.
Other investigators, as well as our own, have
demonstrated that disturbances in colonic moti-
lity may be related to fluctuating levels of IL-1,
PAF and eicosanoids in both TNB and PAF
models of colonic inflammation.’8-x We spec-
ulate from our previous studies involving altera-
tions in colonic neuropeptides that disturbance
in colonic motility may be related to a mechan-
ism involving arachidonic acid metabolites
released during inflammation and neuropeptide
fluctuations. Presently, our data suggest that VIP
is suppressed by C difficile and may participate
in colonic dysmotility disturbances during inflam-
matory states of the left colon. Studies are in
progress to determine whether neural blockade
or pretreatment with synthetic VIP antagonists
antagonize the changes in neuropeptide release,
inflammation and motility changes seen by C. df
ficile.
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